Figure 3

Adjusted β linear regression estimates with 95% confidence intervals of the effect on PWV and distensibility of a ΔCt increase (decreased expression) of the different miRs applied to overall population. The models were adjusted for RA disease onset, body mass index, age, ischaemic heart disease, ictus, hypertension, dyslipidaemia, type 2 diabetes mellitus, disease-modifying antirheumatic drugs, biological agents, corticosteroids, and non-steroidal anti-inflammatory drugs.